Fisher & Paykel HealthcareFSPKF +9.59%90 Dividend Payout Ratio is 0.44 as of Mar. 2026, which is 28% below its 10-year median of 0.61. GuruFocus rates FSPKF with a GF Score™ of 90/100 and a GF Value™ of $27.38 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 281 Medical Devices & Instruments companies, Fisher & Paykel Healthcare ranks worse than 62.28% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Fisher & Paykel Healthcare's Dividend Payout Ratio for the
months ended in Mar. 2026 was 0.44.
The historical rank and industry rank for Fisher & Paykel Healthcare's Dividend Payout Ratio or its related term are showing as below:
FSPKF'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.35 Med: 0.61 Max: 1.81
Current: 0.54
During the past 13 years, the highest Dividend Payout Ratio of Fisher & Paykel Healthcare was 1.81. The lowest was 0.35. And the median was 0.61.
FSPKF's Dividend Payout Ratio is ranked worse than 62.28% of 281
companies
in the Medical Devices & Instruments industry
Industry Median: 0.42
vs FSPKF: 0.54
During the past 13 years, the highest Trailing Annual Dividend Yield of Fisher & Paykel Healthcare was 2.15%. The lowest was 0.68%. And the median was 1.34%.
During the past 12 months, Fisher & Paykel Healthcare's average Dividends Per Share Growth Rate was 2.40% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -0.80% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 5.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 12.20% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Fisher & Paykel Healthcare was 20.50% per year. The lowest was -0.80% per year. And the median was 7.30% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Fisher & Paykel Healthcare (OTCPK:FSPKF) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Fisher & Paykel Healthcare Dividend Payout Ratio Related Terms
Fisher & Paykel Healthcare Dividend Payout Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare Dividend Payout Ratio Chart
FSPKF vs ISRG, BDX, MDLN: Dividend Payout Ratio Comparison
For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fisher & Paykel Healthcare Dividend Payout Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Fisher & Paykel Healthcare's Dividend Payout Ratio falls into.
Fisher & Paykel Healthcare Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Fisher & Paykel Healthcare's Dividend Payout Ratio for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fisher & Paykel Healthcare (FSPKF) has a Dividend Payout Ratio of 0.44 as of Mar. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Fisher & Paykel Healthcare and its competitors. This is 28% below median its historical median of 0.61. Over the past decade, Fisher & Paykel Healthcare's Dividend Payout Ratio has ranged from 0.35 to 1.81. According to the industry distribution chart, Fisher & Paykel Healthcare ranks #175 out of 281 companies in the Medical Devices & Instruments industry, placing it in the top 62.3%.
Is Fisher & Paykel Healthcare's Dividend Payout Ratio too high?
Fisher & Paykel Healthcare's current Dividend Payout Ratio of 0.44 is 28% below median its 10-year median of 0.61. Over the past 10 years, this metric has ranged from a low of 0.35 to a high of 1.81. The Medical Devices & Instruments industry median Dividend Payout Ratio is 0.42. Fisher & Paykel Healthcare's value of 0.44 is 4.8% above this industry median. Based on the distribution chart, Fisher & Paykel Healthcare ranks #175 out of 281 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Fisher & Paykel Healthcare has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Dividend Payout Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fisher & Paykel Healthcare ranks #175 out of 281 companies for Dividend Payout Ratio. This places Fisher & Paykel Healthcare in the lower half of its industry. The industry median Dividend Payout Ratio is 0.42. Fisher & Paykel Healthcare's value of 0.44 is 4.8% above this benchmark. Historically, Fisher & Paykel Healthcare's own Dividend Payout Ratio has ranged from 0.35 to 1.81 over the past decade. While the company's 10-year median is 0.61 vs. the industry median of 0.42, Fisher & Paykel Healthcare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Medical Devices & Instruments company?
The median Dividend Payout Ratio among Medical Devices & Instruments companies is 0.42, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fisher & Paykel Healthcare's current Dividend Payout Ratio of 0.44 is 4.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Fisher & Paykel Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Dividend Payout Ratio is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fisher & Paykel Healthcare's current Dividend Payout Ratio is 0.44, which is 28% below median its own 10-year median of 0.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (FSPKF) is currently considered Modestly Undervalued. The stock's GF Value™ is $27.38, compared to a current price of $22.52 — trading 17.8% below its estimated fair value. The current Dividend Payout Ratio is 0.44, which is 28% below median its 10-year median of 0.61 and 4.8% above the Medical Devices & Instruments industry median of 0.42. Fisher & Paykel Healthcare's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Fisher & Paykel Healthcare (FSPKF), the current Dividend Payout Ratio is 0.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fisher & Paykel Healthcare (FSPKF) Overvalued in 2026?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued.
The current stock price of $22.52 is trading 17.8% below its estimated GF Value™ of $27.38.
GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.
Key valuation signals for FSPKF:
Dividend Payout Ratio: 0.44 (28% below median its 10-year median of 0.61)
GF Value™: $27.38 vs. price of $22.52 (17.8% below fair value)
Industry Position: 4.8% above the Medical Devices & Instruments median (#175 of 281)
No single metric tells the full story. See the FSPKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
90GF Score
Get the complete analysis for FSPKF
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FSPKF has been successfully added to your 
